The D2 dopamine receptor isoforms signal to a variety of cellular effectors in both the central nervous system and periphery. Two alternative splice forms of the D2 dopamine receptor exist, the D2s (short) and D2l (long), which has an insertion of 29 amino acids in the third intracellular loop (Dal Taso et al., 1989). In cells of the anterior lobe of the pituitary, D2 dopamine receptors (both forms) are present on lactotroph cells coupled to the inhibition of adenylyl cyclase, activation of voltage-gated calcium channels, and inhibition of potassium channels. We describe here a novel signaling pathway for the D2s, which is the activation of phospholipase D (PLD). GH4C1 cells, a clonal line derived from a rat pituitary tumor, were stably transfected with the gene encoding the D2s, generating GH4-121 cells.
Treatment of GH4-121 cells with a dopaminergic agonist resulted in activation of PLD in both a dose-dependent and time-dependent manner. This signaling pathway was not inhibited by prior treatment of cells with pertussis toxin at concentrations that ablate other D2s receptor signaling in this cell line. The stimulation of PLD activity by D2s appeared to correlate with the presence of a specific protein kinase C isoform, PKC⑀. The D2s stimulation of PLD activity was blocked by preincubation of cells with C3 exoenzyme, indicating that the stimulation of PLD may involve Rho family members. The stimulation of PLD by dopaminergic agonists took place in the absence of any detectable stimulation of phosphoinositide metabolism.
Dopamine acts through several classes of membrane receptors to effect cellular responses (Gingrich and Caron, 1993; Missale et al., 1996) . The D2 dopamine receptor family has two isoforms, long and short, which arise from alternative splicing of mRNA (Dal Toso et al., 1989) . The two forms of the D2 dopamine receptor are pleiotropic in terms of transmembrane signaling because activation of these receptors inhibits adenylyl cyclase (McDonald et al., 1982) and results in inhibition of voltage-gated calcium currents (Lledo et al., 1992) and activation of potassium conductance (Einhorn et al., 1991) . It has been shown previously that these processes are mediated through the G i /G o family of G proteins because the signaling through these pathways can be ablated by the treatment with pertussis toxin (PTX). A well studied system for D2 dopamine receptor function is the lactotroph cells of the anterior lobe of the pituitary, where activation of the D2 dopamine receptors results in inhibition of prolactin release. A clonal cell line conveniently used for study of lactotrophs is the GH4C1 cell line, cloned from a radiation-induced rat pituitary tumor (Tashjian et al., 1968) . These cells secrete both prolactin and growth hormone basally and in response to secretagogues, as do primary cultures of isolated lactotroph. However, these clonal cells do not respond to dopamine or express high affinity D2 dopamine receptors (Malarkey et al., 1977; Cronin et al., 1980) . When stably transfected with the cDNA encoding the D2s, the response of these cells to dopamine is very similar to that of normal lactotrophs; dopamine inhibits forskolin-stimulated adenylyl cyclase and prolactin release .
Phosphatidylcholine-specific phospholipase D (PLD) enzymes have been implicated in many regulatory roles in cells, including mitogenesis, oncogenesis, and regulation of metabolism (Exton, 1997) . PLD catalyzes the hydrolysis of phosphatidylcholine to phosphatidic acid (PA) and choline. PA and the diacylglycerol produced from dephosphorylation of PA by phosphatidate phosphohydrolase are active signaling molecules, implicated in a variety of cellular signaling pathways. Several mammalian forms of PLD have recently been cloned: PLD1 a and b (Hammond et al., 1995 (Hammond et al., , 1997 and PLD2 (Kodaki and Yamashita, 1997) . PLD1 isoform activity is reported to be dependent on phosphatidylinositol 4,5-bisphosphate and stimulated by Rho and ARF-1 small GTP family proteins and protein kinase C (PKC)-␣ (Hammond et al., 1995 (Hammond et al., , 1997 . The PLD2 enzyme appears to be dependent on phosphatidylinositol 4,5-bisphosphate but is not further stimulated by Rho, ARF-1, or PKC␣ in vitro (Kodaki and Yamashita, 1997) .
The mechanisms by which G protein-coupled receptors stimulate PLD are not completely understood, although there appears to be a PKC-dependent pathway that commonly involves activation of phospholipase C (PLC), and a PKC-independent pathway. Prolonged treatment with phorbol esters will ablate the ability of many G protein-coupled receptors mediated to stimulate PLD (for review, see Exton, 1997) , including the D2s (Senogles, 1994a) . This suggests that receptors which signal through the PKC-dependent pathways activate PLC, generating diacylglycerol (DAG) and IP3, which in turn activates PKC. Indeed, this PKC-dependent activation has been correlated with a concomitant stimulation of PLC because many receptors can stimulate both PLD and PLC activities, such as the muscarinic M1-M4 receptors and endothelin receptors (Sandman et al., 1991; Ambar and Sokolovsky, 1993; Bocchino and Exton, 1996) . Few G protein-coupled receptors have been reported to stimulate PLD without a concomitant increase in PLC, as described for the D2s in this study and for the ␣ 2 -adrenergic receptor (MacNulty et al., 1992) . This study describes the activation of PLD by the D2s, without accompanying PLC activity and in a manner that correlates with the presence of a specific PKC isoform.
Previously, my laboratory demonstrated that the inhibition of [ 3 H]thymidine incorporation mediated by D2s involves PKC because phorbol ester down-regulation and PKC inhibitors blunt the ability of dopamine to inhibit [ 3 H]thymidine incorporation (Senogles, 1994a) . Further investigation revealed that PKC⑀ is involved because selective removal of PKC⑀ by longterm treatment with thyrotropin releasing hormone (TRH) had the same effect as treatment with phorbol esters. Because previous data had suggested the involvement of PKC in the growth inhibition by dopamine, we were interested in potential sources of activators of PKC. Many previous investigators had shown that the activation of D2 dopamine receptors in lactotrophs did not result in the stimulation of polyphosphoinositide metabolism (Vallar et al., 1990) . To identify other potential sources of DAG, we investigated the ability of dopamine to stimulate PLD activity in GH4-121 cells. As reported here, agonist activation of D2s receptors results in a stimulation of PLD activity in GH4-121 cells, with no concomitant activation of PLC. The ability of dopamine agonists to stimulate PLD activity is not PTX-sensitive and is correlated with the presence of PKC⑀. Selective down-regulation of PKC⑀ abolishes the ability of dopamine agonists to stimulate PLD. This down-regulation by TRH is selective for PKC⑀ because the other isoforms of PKC were unaffected by treatment as determined by Western blotting analysis with isoform-specific antibodies. In addition, incubation with C3 exoenzyme ablates the ability of dopaminergic agonists to stimulate PLD, implicating Rho in this signaling cascade. Thus, the D2s-mediated stimulation of PLD activity appears to be independent of PLC activity but may be dependent on Rho. These data suggest a novel signaling pathway for the D2s.
Experimental Procedures Materials
Ham's F10, fetal calf serum (certified), and G418 sulfate were all obtained from Life Technologies (Gaithersburg, MD 
Methods
Cell Culture. GH4C1 cells were cultured in Ham's F10 medium, supplemented with 7.5% heat-inactivated fetal calf serum and 2.5% heat-inactivated horse serum with 50 g/ml gentamicin, and grown in a 5% CO 2 environment at a constant 37°C. Stable transfectants of GH4C1 were generated and characterized as described previously (Senogles, 1994b) . The cells were routinely grown in medium containing 400 g/ml G418 (205 g of active compound).
PLD Assays. PLD assays were performed by the method of Sandman et al. (1994) with some minor modifications. Cells were plated in 12-well cluster dishes at a density of approximately 250,000 cells/ well and labeled for 24 to 48 h before assay by addition of 10 Ci/well of [ 3 H]myristic acid. For the assay, the cells were washed twice with PBS (25°C) to remove serum and were incubated in 2 ml of Dulbecco's modified Eagle's medium in a shallow water bath at a temper- ature of 37°C. The agonists or drugs of interest were added to the cells, along with 0.5% ethanol as appropriate. The assay was allowed to incubate for 30 min at 37°C and was terminated by removal of the assay medium and addition of 1 ml of methanol, 2 M HCl (9:1 v/v). Cells were scraped and the wells were rinsed with an additional 1 ml of 0.25 M HCl, which was combined with the original cell scraping. The combined samples were extracted with 1 ml of chloroform, and the chloroform layer was removed and dried by vacuum evaporation. The dried samples were resuspended in a total volume of 50 l with CHCl 3 /methanol (9:1), and 5 l of PtdEtOH (0.5 mg/ml) was added to each sample as an internal standard. The samples were spotted on silica G plates, along with standards for the phosphatidylcholine, PA, and PtdEtOH, and developed in a solvent containing CHCl 3 / acetone/methanol/acetic acid/water (100:40:25:20:10 v/v). The phospholipid bands were visualized by staining with elemental iodine, and the bands corresponding to PA, phosphatidylcholine, and PtdEtOH were scraped and quantified by liquid scintillation counting. The data were normalized by expressing the PtdEtOH as a percentage of the total cellular phosphatidlycholine.
Inositol Phosphate Accumulation. GH4-121 cells were labeled for 2 days with 5 Ci/ml [ 3 H]inositol. The cells were washed with prewarmed Krebs buffer and incubated with 10 mM lithium chloride in the presence of agonist for 10 min or as designated at 37°C. The reactions were stopped by the addition of 1 ml of MeOH, 2 M HCl (9:1) and placed on ice. The cells were scraped, and the plates were washed with an additional 0.5 ml of water that was added to the initial cell homogenate. The samples were centrifuged, and the supernatants extracted with CHCl 3 . The aqueous phase was subjected to Dowex chromatography to fractionate the inositol phosphates as described (Berridge et al., 1983) .
PTX Treatment. GH4-121 cells were treated with PTX as follows. GH4-121 cells were seeded at the usual density in 24-well cluster dishes in Ham's F10 medium with the usual serum supplementation. PTX treatment of the GH4-121 cells was performed for 12 to 16 h at 37°C, using a concentration of PTX (20 ng/ml), which has been shown previously to fully ADP-ribosylate the G i /G o family of proteins in these cells (Senogles, 1994b) .
C3 Exoenzyme Treatment. GH4-121 cells were washed with PBS and then placed in a buffer containing 114 mM KCl, 15 mM NaCl, 5.5 mM MgCl 2 , and 10 mM Tris-HCl. C3 exoenzyme (final concentration, 25 g/ml) was added to the cells. The cells were scraped as described (Malcolm et al., 1996) , plated into 6-well cluster dishes, and allowed to recover for 48 h. The viability of scrape-loaded cells, as assessed by exclusion of Trypan Blue, was quite variable, ranging from 50 to 80%.
ADP-Ribosylation Using [ 32 P]NAD. To test for the effectiveness of C3 exoenzyme treatment, cells were prepared by scrapeloading and allowed to culture for 48 h. Membranes from GH4-121 cells were prepared as described (Senogles, 1994b) , and ADP-ribosylation of the membranes using [ 32 P]NAD was performed as previously described (Malcolm et al., 1994) . The samples were subjected to SDS-polyacrylamide gel electrophoresis (PAGE), and the gel was visualized by autoradiography.
Western Blotting. The cells were washed with PBS, scraped into microfuge tubes, and centrifuged at 13,000g for 15 min. The crude pellet was resuspended in Laemmli sample buffer containing 5% SDS. The samples were subjected to SDS-PAGE and the gels were blotted for 1 h at 100 V onto nitrocellulose using 192 mM glycine, 25 mM Tris ϩ 20% methanol. The blots were blocked by 1 h of incubation with PBS containing 3% nonfat dry milk ϩ 0.05% Tween 20 and incubated overnight with the primary antibody at 4°C. The next morning, the blots were washed with PBS ϩ 0.3% Tween 20 for 15 min, followed by two washes with PBS. The second antibody, goat anti-rabbit-conjugated horseradish peroxidase, was incubated for 1 h 
Results

D2s
Receptors Stimulate PLD Activity in GH4-121 Cells. PLD catalyzes the hydrolysis of phospholipids, resulting in the generation of PA and the release of the polar head group (for review, see Exton, 1998 Exton, , 1999 Nishizuka, 1992) . To date, many G protein-coupled receptors have been shown to stimulate PLD activity, such as m1-m4 muscarinic, ␣ 2 -adrenergic and endothelin receptors (Exton, 1994) . PLD has been shown to be stimulated by the addition of phorbol esters or the calcium ionophore, ionomycin (Exton, 1994) . As shown in Fig. 1 (panel A) , the PLD activity of GH4C1 cells (the parent cell line of GH4-121 cells) is stimulated 15.4-and 13.7-fold over basal activity by these agents, respectively. The active phorbol ester, 4␤-phorbol 12,13-didecanoate (4␤PDD) stimulates PLD activity, whereas the inactive isomer, 4␣-phorbol 12,13-didecanoate (4␣PDD), is ineffective. Treatment of cells with NPA (D2 agonist) had no effect on PLD stimulation. Stable transfection of the D2s into GH4C1 yields GH4-121 cells (21). This cell line has the same re- Fig. 3 . Time course of D2s-stimulated PLD activity. The time course of PLD activity was measured by labeling with [ 3 H]myristic acid and assaying PLD activity at the time points shown after addition of agonist, 10 nM NPA, at time zero. Duplicate assays were performed in the presence (PtdEtOH) or absence (PA) of ethanol, and the cellular lipids were extracted and separated as described under Methods. These data represent the mean and S.D. of three independent experiments. 6 . Effect of down-regulation of PKC on PKC isozyme expression. Cells were pretreated with the following conditions: 1) 10 nM TRH, 2) 10 nM 4␤PDD, 3) 10 nM 4␣PDD, and 4) control for 18 h. The cells were prepared for SDS-PAGE and Western blotting as described under Methods. The primary antisera were PKC isoform-specific antisera, and the blot was visualized by incubation with anti-goat-conjugated horseradish peroxidase using Opti-4CN substrate. This blot is representative of three independent experiments. sponse to phorbol ester and ionomycin as the parent cell line (Fig. 1, panel B) . In addition, activation of the D2s by agonist results in a stimulation of PLD activity (Fig. 1, panel B) . The PLD activity of GH4-121 cells is stimulated in a dose-dependent manner by addition of D2s agonists: NPA, bromocriptine, and dopamine (Fig. 2, panel A) . The EC 50 for activation of PLD by NPA is approximately 300 pM (data not shown). The activation of PLD by dopamine agonists is completely blocked by inclusion of antagonists for the D2s, such as (ϩ) butaclamol and spiperone (Fig. 2, panel B) but not by either a D1 dopamine receptor antagonist (SCH 23390) or a serotonin antagonist (ketanserin). These data indicate that the stimulation of PLD activity is a result of a receptor-mediated signaling event in GH4-121 cells.
Time Course for D2s-Stimulated PLD Activity. The time course for D2s-stimulated PLD activity is shown in Fig. 
The GH4-121 cells labeled with [
3 H]myristic acid were assayed for the production of both PA and PtdEtOH as a function of time, with agonist added at zero time. As shown, the production of PA and PtdEtOH was not detected until 5 min after addition of agonist. The stimulation of PLD by agonist is maximal at approximately 30 to 40 min.
PTX Sensitivity of D2s-Stimulated PLD Activity. As stated previously, the activation of the D2s has been shown to inhibit forskolin-stimulated adenylyl cyclase, activate K ϩ channels, and inhibit voltage-sensitive Ca 2ϩ channels. All of these signaling events are sensitive to treatment with PTX, which will covalently modify members of the G i /G o family of G proteins by ADP ribosylation. In contrast, the ability of D2 dopamine agonists to inhibit growth in GH4ZR7 (another cell line derived from GH4C1 stably transfected with D2s) cells as assessed by [ 3 H]thymidine incorporation is not sensitive to the actions of PTX (Senogles, 1994a) . As shown in Fig. 4 , the ability of D2s to stimulate PLD is not blocked by PTX treatment. The stimulation of PLD activity by both 10 and 100 nM NPA was unaffected by pretreatment of the cells with 20 or 50 ng/ml PTX (data not shown). The ability of phorbol 12-myristate 13-acetate (PMA) to stimulate PLD was not affected by treatment of the cells with PTX. An experiment was performed in parallel, assessing the dopamine receptor-mediated inhibition of forskolin-stimulated adenylyl cyclase (data not shown). This experiment showed that pretreatment with 20 ng/ml PTX fully ablated the ability of dopamine to inhibit forskolin-stimulated adenylyl cyclase as previously reported (Senogles, 1994b) . It should be noted that overnight treatment with 20 ng/ml PTX has been previously shown to modify Ͼ98% of the G i /G o proteins in this cell line (Senogles, 1994b) .
Effect of Phorbol Ester Treatment on D2s Stimulation of PLD Activity. Previous work (Senogles, 1994a) has shown that the inhibition of [ 3 H]thymidine incorporation mediated by dopamine could be blunted by down-regulation of PKC using phorbol esters or by the use of PKC inhibitors. Moreover, the involvement of PKC⑀ was determined by specific down-regulation of PKC⑀ using treatment with TRH. Because phorbol esters were shown to stimulate PLD activity in GH4-121 cells (Fig. 1) , we chose to investigate the effect of down-regulation of PKC on PLD activity using both phorbol ester and TRH pretreatment. Shown in Fig. 5 are four pretreatment conditions: 1) control (vehicle); 2) 100 nM 4␤PDD for 18 h; 3) 100 nM 4␣PDD for 18 h; and 4) 10 nM TRH for 18 h before assay of PLD. After the pretreatment protocols, the GH4-121 cells were assayed for both NPA and phorbol ester-stimulated PLD activity. Downregulation with 4␤PDD, the active phorbol ester, abolishes both the NPA and phorbol ester activation of PLD. In contrast, down-regulation with the 4␣PDD (the inactive isomer) has no effect on subsequent activation of PLD by either NPA or 4␤PDD. Long-term treatment with TRH (Ͼ18 h), shown previously to ablate the ability of dopamine to inhibit growth and [ 3 H]thymidine incorporation, also blunted the stimulation of PLD evoked by NPA but not by phorbol esters.
Effect of Phorbol Ester and TRH Treatment on the PKC Isoforms in GH4-121 Cells. GH4C1 cells contain several isoforms of PKC: ␣, ␤, ␥, ⑀, and (Kiley et al., 1990 (Kiley et al., , 1991 . The PKC isoforms ␣, ␤, and ␥ are conventional, Ca 2ϩ -dependent enzymes, which can be down-regulated by treatment with phorbol ester (for review, see Nishizuka, 1992) . PKC⑀ is a novel isoform not dependent on calcium but down- molpharm.aspetjournals.org regulated with phorbol ester treatment. PKC is an atypical isoform and is not regulated by either calcium or phorbol ester treatment. The GH4-121 cells were treated with 10 nM 4␣PDD, 10 nM 4␤PDD, or 10 nM TRH for 18 h before cell lysis. Western blot analysis with isoform-specific antibodies was performed to determine the effect of various agents on PKC isoform expression. As shown in Fig. 6 , PKC␣, -␤, -␥, and -⑀ were effectively down-regulated by prolonged exposure to 4␤PDD (lane 2), compared with the control (lane 4), but exposure to 4␣PDD (lane 3) had no effect. In contrast, only PKC⑀ expression was affected by prolonged TRH treatment (lane 1). PKC expression was unaffected by any of the treatments.
Effect of Dopaminergic Agonists on Phosphoinositide Metabolism. GH4-121 cells were assayed for the ability of dopaminergic agonists to stimulate the production of inositol phosphates. Cells were incubated with TRH, bombesin, and NPA for 10 min, and the inositol phosphates were isolated. As shown in Fig. 7 , TRH and bombesin stimulated the accumulation of inositol phosphates at 10Ј. In contrast, NPA had no effect on accumulation of either IP3 or IP1 ϩ IP2. Incubation times of 30 min gave the same results, with no detectable inositol phosphates generated by NPA (data not shown).
Effect of C3 Exoenzyme on D2s Stimulation of PLD. Previous work has shown that Rho, a member of the small G protein family, can be inactivated by C3 exoenzyme, a toxin from Clostridium botulinum by covalent modification. Because Rho family members have been implicated in regulation of PLD (for review, see Exton, 1998 Exton, , 1999 , it was of interest to test the effects of C3 treatment on the D2s stimulation of PLD activity. C3 exoenzyme was scrape-loaded into GH4-121 cells, and the effect of toxin treatment on D2s stimulation of PLD was monitored. As shown in Fig. 8A , C3 exoenzyme treatment blocks Ͼ95% of NPA stimulation of PLD activity. The C3 exoenzyme treatment also decreases both 4␤PDD and ionomycin stimulation by approximately 50%. Shown in panel B, is the autoradiogram of the SDS-PAGE of the in vitro ADP ribosylation of GH4-121 cells using C3 and [ 32 P]NAD before and after scrape-loading with C3 exoenzyme. As shown, cells that were not treated with C3 exoenzyme could be labeled in vitro with C3 exoenzyme and [ 32 P]NAD, whereas the pretreated cells did not incorporate significant amounts of label. The data suggest that the C3 exoenzyme was indeed loaded into the GH4-121 cells and was able to modify the Rho proteins. Taken together, these data suggest a role for Rho in the D2s signaling to PLD in these cells.
Discussion
The data presented in this study suggest D2 dopamine agonist activation of PLD activity in GH4-121 cells. The activation of PLD activity was dose-dependent and pharmacologically selective. The ability of agonists to stimulate PLD activity and of antagonists to block activation has a selectivity and potency that is appropriate for the D2s. The parent cell line, GH4C1, does not show a PLD response to dopaminergic agonists, which underscores that the effect observed is through activation of the D2s receptor. These combined data suggest that the stimulation of PLD activity is due to a receptor-mediated event.
PLD has been shown to be activated by a number of G protein-coupled receptors, including the m1-m4 muscarinic (Sandman et al., 1991) , endothelin (Ambar and Sokolovsky, 1993) , ␣ 2 -C10 adrenergic receptors (MacNulty et al., 1992) , and many others (Bocchino and Exton, 1996) . For most of these receptors, activation of PLD is concomitant with activation of PLC. Thus, these receptors can bring about activation of PLD by a PKC-dependent mechanism. DAG generated from the PLC appears to activate PKC, which either directly acts on PLD or acts in concert with small G proteins to Fig. 8 . Effect of C3 exoenzyme treatment on PLD activity. Cells were treated by scrape-loading GH4-121 cells in the presence or absence of 20 g/ml C3 exoenzyme (Ⅺ, control; f, ϩ C3 exoenzyme). The cells were labeled and assayed for PLD activity (panel A). These data represent the mean and S.D. of four independent experiments. Membranes were prepared from GH4-121 cells and GH4-121 cells that had been scrape-loaded with C3 exoenzyme. These membranes were ADP-ribosylated in vitro using [ 32 P]NAD and C3 exoenzyme as described under Experimental Procedures. The samples were subjected to SDS-PAGE and the gels were visualized by autoradiography. A scan of the gel is shown in panel B with the position of the molecular weight markers indicated.
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Senogles at ASPET Journals on August 14, 2017 molpharm.aspetjournals.org activate PLD (Exton, 1998 (Exton, , 1999 . In contrast, the studies presented here for the D2s indicate a novel pathway for the stimulation of PLD, because concomitant activation of PLC is not involved.
Similar to the D2s effects described in this study, the ␣ 2 -adrenergic receptor has been shown to stimulate PLD without a concomitant stimulation by PLC (MacNulty et al., 1992) . The stimulation of PLD by the ␣ 2 -adrenergic receptor was suggested to be inappropriate receptor coupling due to overexpression of the receptor in a heterologous cell line. Heterologous expression of the D2s has been shown to lead to aberrant signaling, such as that observed in Ltk cells (Vallar et al., 1990) . However, the parent cell line used for this study is the GH4 clonal line, derived from a pituitary tumor. Transfection of the D2s into GH4 cell lines has resulted in cell lines that respond to dopamine agonists similar to lactotroph cells in culture , in terms of signaling and cellular response, such as prolactin release. Also, the expression of D2s receptor in this cell line is quite low, only 300 fmol/mg of protein as assessed by [ 3 H]spiperone binding (S. Senogles, unpublished data). The EC 50 for NPA activation of PLD is approximately 300 pM (data not shown). This is comparable with the EC 50 value of 500 pM obtained for NPA-mediated inhibition of forskolin-stimulated adenylyl cyclase (Senogles, 1994b) . These combined data argue against the stimulation of PLD observed in GH4-121 cells as being due to overexpression of receptor, however transfection artifacts cannot be completely ruled out.
PLD has been shown to be regulated by the actions of several isoforms of PKC. For example, several studies have shown that overexpression of PKC␣ and PKC␤ results in stimulated PLD (Pai et al., 1991; Pachter et al., 1992; Eldar et al., 1993; Conricode et al., 1994) . In addition, PKC⑀ has been shown to mediate the stimulation of PLD activity in rat mesangial cells (Pfeilschifter and Merriweather, 1993) . In studies of the cloned and expressed PLD isoforms, PKC␣ stimulated the activity of the PLD1 isoform in vitro (Hammond et al., 1995 (Hammond et al., , 1997 . Our studies have shown a correlation between the presence of PKC⑀ and D2s-mediated stimulation of PLD. The down-regulation of PKC⑀, selectively by treatment with TRH, ablated the ability of dopaminergic agonists to stimulate PLD. Western blot analysis of cells treated with TRH indicated that only the PKC⑀ isoform was affected by this treatment, whereas phorbol ester treatment resulted in down-regulation of PKC␣, -␤, -␥, and -⑀. However, a direct role for PKC⑀ in the D2s stimulation of PLD has not been shown, and the role of PKC⑀ in this pathway remains unclear. The long-term treatment with TRH needed to downregulate PKC⑀ may impact cellular signaling in a myriad of ways. For example, long-term stimulation with TRH could deplete various lipid pools or many other cofactors and cause a loss of PLD stimulation.
The mechanism by which the D2s stimulate PLD activity is still undefined. The activation of PLD by dopaminergic agonists is insensitive to the actions of PTX and would suggest that the G i /G o family of proteins is not involved in this pathway, as they are in other signaling pathways stimulated by the D2s. In this study, C3 exoenzyme has been shown to ablate D2s stimulation of PLD. One explanation for the stimulation of PLD by D2s is that there is a direct interaction of the D2s with Rho family small G proteins. Previous work has suggested that the motif NPXXY in the seventh transmembrane spanning domain of G protein-coupled receptors can predict the ability of the receptor to interact directly with Rho and ARF to stimulate PLD (Mitchell et al., 1998) . The D2s contains this motif (Bunzow et al., 1988) , and one hypothesis to explain these data may be the direct interaction of D2s with small G to activate PLD. The details of the mechanism by which D2s stimulates PLD activity remain unclear and will be the focus of future investigations.
